Tag: Emma Reynolds

  • Emma Reynolds – 2015 Parliamentary Question to the Department of Health

    Emma Reynolds – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Emma Reynolds on 2015-11-16.

    To ask the Secretary of State for Health, if he will publish data on molecular genetic test activity rates in 2012-13 and each subsequent year.

    George Freeman

    Data on molecular genetic testing for 2012-13 and subsequent years are not currently held centrally. The UK Genetic Testing Network (UKGTN) is working to publish data on molecular testing activity in collaboration with the Health and Social Care Information Centre (HSCIC) and NHS England. UKGTN is also working with the devolved administrations to ensure that they are legally able to share these data with the HSCIC.

  • Emma Reynolds – 2015 Parliamentary Question to the Department for Communities and Local Government

    Emma Reynolds – 2015 Parliamentary Question to the Department for Communities and Local Government

    The below Parliamentary question was asked by Emma Reynolds on 2015-12-15.

    To ask the Secretary of State for Communities and Local Government, what UK projects received funding under the European Regional Development Fund 2007-2013; what the location of each such project was; and what the amount received in funding was for each such project.

    James Wharton

    In the 2007-13 programmes, the grant recipients of the European Regional Development Fund generally had to deliver the projects across the region covered by that programme; location details for those grant recipients have been provided and are shown in the attached table.

  • Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Emma Reynolds on 2016-01-27.

    To ask the Secretary of State for Health, what steps his Department has taken to increase access to specialist community perinatal mental health care.

    Alistair Burt

    This Government is committed to improving access to perinatal mental health services for women during pregnancy and in the first postnatal year. In January 2016 the Government set out that an additional £290 million will be made available over the next five years to 2020/21, over and above the money identified in the Spring Budget, to invest in perinatal mental health services. This is funded from within the Department’s overall Spending Review settlement and means that in total from 2015/16 to 2020/21 £365 million will be invested in perinatal mental health services.

    We are aware that there is unacceptable variation in the levels of access to high quality, NICE-recommended specialist perinatal mental health care for women across England. A 2014 census identified that 40% of women in England have no access to specialist perinatal mental health services and that is why we have confirmed this additional investment. The funding should enable significant progress towards closing this gap and will help to enable women across the country to access evidence-based specialist support, in the community or through inpatient mother and baby services, closer to their home, when they need it. It is anticipated that, by 2020/21, around 30,000 more women should be able to access appropriate specialist support.

    This new funding, together with the recommendations of the forthcoming report of the independent Mental Health Taskforce, will enable NHS England to work with partners to design a longer-term transformation programme to build capacity and capability in specialist perinatal mental health services over the next five years. This will include setting detailed plans for how the additional investment will be targeted over the period to 2020/21 and setting clear outcome measures and metrics to monitor the impact of the funding on perinatal mental health provision.

    In 2015/16 work is already underway to lay the foundations for this longer-term work programme through targeted funding of activities to build capacity in specialist services. This will include, for example, a £1 million investment in strengthening clinical networks across the country. It is also expected to include the provision of national and regional benchmarking data and analytical support to regions, and work to develop clinical leadership capacity. Work will also continue to support the development of specialist mother and baby units in the regions identified as most in need of new services.

    To ensure the workforce are available and appropriately trained, NHS England is working closely with Health Education England and key stakeholders to better understand the future workforce commissioning requirements and how it is best to meet multi professional education and training needs.

  • Emma Reynolds – 2016 Parliamentary Question to the Department for Exiting the European Union

    Emma Reynolds – 2016 Parliamentary Question to the Department for Exiting the European Union

    The below Parliamentary question was asked by Emma Reynolds on 2016-07-21.

    To ask the Secretary of State for Exiting the European Union, what the Government’s policy is on access to the European Economic Area; and if he will make a statement.

    Mr Robin Walker

    Our economy is fundamentally strong, and the UK is open to business and investment. The Government has been consulting, and will continue to consult, with a broad range of stakeholders and we will need to consider all factors carefully in implementing the decision of the British people. This is clearly a very important issue for UK business and we will want the strongest possible economic links with our European neighbours.

  • Emma Reynolds – 2015 Parliamentary Question to the Department of Health

    Emma Reynolds – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Emma Reynolds on 2015-11-16.

    To ask the Secretary of State for Health, if he will require a UK Genetics Testing Network to audit Clinical Commissioning Policy: Genetic Testing for BRCA1/2 Mutations, published by NHS England in 2014.

    George Freeman

    NHS England published a new Clinical Commissioning Policy on Genetic Testing for BRCA1/2 mutations in July 2015, based on updated guidelines issued by the National Institute for Health and Care Excellence. Subject to the need to appropriately handle patient identifiable data, NHS England would be willing to work with the UK Genetic Testing Network (UKGTN) to consider and monitor changes in uptake of BRCA testing following the publication of the 2015 Clinical Commissioning Policy.

  • Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Emma Reynolds on 2016-01-05.

    To ask the Secretary of State for Health, whether those who have suffered the loss of a child at birth under the current litigation regime will still be able to claim compensation under a fixed recoverable costs regime.

    Ben Gummer

    The Department is currently preparing to go out to public consultation on the introduction of Fixed Recoverable Costs (FRC) for clinical negligence claims.

    We can confirm there are no plans to limit the amount of damages awarded for clinical negligence claims and so parties will still be able to claim compensation under a FRC regime.

  • Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Emma Reynolds on 2016-01-27.

    To ask the Secretary of State for Health, what plans his Department has to improve the identification and treatment of perinatal mental health issues; and how this will be monitored.

    Alistair Burt

    This Government is committed to improving access to perinatal mental health services for women during pregnancy and in the first postnatal year. In January 2016 the Government set out that an additional £290 million will be made available over the next five years to 2020/21, over and above the money identified in the Spring Budget, to invest in perinatal mental health services. This is funded from within the Department’s overall Spending Review settlement and means that in total from 2015/16 to 2020/21 £365 million will be invested in perinatal mental health services.

    We are aware that there is unacceptable variation in the levels of access to high quality, NICE-recommended specialist perinatal mental health care for women across England. A 2014 census identified that 40% of women in England have no access to specialist perinatal mental health services and that is why we have confirmed this additional investment. The funding should enable significant progress towards closing this gap and will help to enable women across the country to access evidence-based specialist support, in the community or through inpatient mother and baby services, closer to their home, when they need it. It is anticipated that, by 2020/21, around 30,000 more women should be able to access appropriate specialist support.

    This new funding, together with the recommendations of the forthcoming report of the independent Mental Health Taskforce, will enable NHS England to work with partners to design a longer-term transformation programme to build capacity and capability in specialist perinatal mental health services over the next five years. This will include setting detailed plans for how the additional investment will be targeted over the period to 2020/21 and setting clear outcome measures and metrics to monitor the impact of the funding on perinatal mental health provision.

    In 2015/16 work is already underway to lay the foundations for this longer-term work programme through targeted funding of activities to build capacity in specialist services. This will include, for example, a £1 million investment in strengthening clinical networks across the country. It is also expected to include the provision of national and regional benchmarking data and analytical support to regions, and work to develop clinical leadership capacity. Work will also continue to support the development of specialist mother and baby units in the regions identified as most in need of new services.

    To ensure the workforce are available and appropriately trained, NHS England is working closely with Health Education England and key stakeholders to better understand the future workforce commissioning requirements and how it is best to meet multi professional education and training needs.

  • Emma Reynolds – 2016 Parliamentary Question to the Department for Exiting the European Union

    Emma Reynolds – 2016 Parliamentary Question to the Department for Exiting the European Union

    The below Parliamentary question was asked by Emma Reynolds on 2016-07-21.

    To ask the Secretary of State for Exiting the European Union, how many trade negotiators are employed by his Department; how many such negotiators his Department plans to recruit; and what estimate his Department has made of the cost of those negotiations.

    Mr David Jones

    Britain has been at the forefront of the free trade-supporting countries in the EU for the last 40 years. The overall size and scope of the new department, including staffing and skill mix, are now under consideration. We will have the right resources in place so we can secure the best possible outcome for the UK as a whole.

  • Emma Reynolds – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    Emma Reynolds – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Emma Reynolds on 2015-11-13.

    To ask the Secretary of State for Business, Innovation and Skills, what the average (a) export and (b) import tariffs paid by the UK to countries with whom the EU has a Free Trade Agreement was in each of the last five years.

    Anna Soubry

    Estimating the average tariffs on UK exports and imports to and from all the countries with which the EU has free trade agreements in each of the last five years would involve a disproportionate cost.

  • Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    Emma Reynolds – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Emma Reynolds on 2016-01-05.

    To ask the Secretary of State for Health, what steps are being taken to ensure that all NHS trusts are (a) identifying patient safety incidents, (b) conducting full investigations to identify the causes of such incidents and (c) implementing measures to prevent recurring such incidents.

    Ben Gummer

    Currently, NHS England has a leadership role for patient safety in the National Health Service and supports providers to identify, understand and manage risks that might affect the safety of patients. The primary source for identifying risks is the National Reporting and Learning System (NRLS). The NRLS operates as a database and holds over 1.4 million locally reported patient safety incidents. These are reviewed to help address the identified issues or risks in the NHS. NHS England alerts NHS trusts of emerging patient safety risks via the National Patient Safety Alerting System – a three-stage alerting process which ensures the timely sharing of relevant safety information. The system also encourages information sharing between organisations so that examples of best practice can be widely adopted.

    NHS trusts are expected to review their own patient safety incidents. The revised Serious Incident Framework published in March 2015 has sought to simplify the incident management process and ensure that serious incidents are identified correctly, investigated thoroughly and, most importantly, learned from to prevent the likelihood of similar incidents happening again.

    The NHS standard contract also stipulates that providers must consider and respond to the recommendations arising from any audit, Serious Incident report or Patient Safety Incident report.